Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Guanine-recognizing enzymes refers to a broad and heterogeneous functional class of proteins rather than a single specific therapeutic target. This group encompasses a wide variety of enzymes that interact with guanine or its derivatives, including GTPases (G proteins) involved in signal transduction, guanylate cyclases that produce second messengers, and enzymes of the purine salvage pathway such as hypoxanthine-guanine phosphoribosyltransferase (HGPRT). Because this category includes proteins with vastly different structures, localizations, and biological roles, it is considered too broad for specific drug development or target annotation. Therapeutic interventions typically focus on specific members within this class, such as KRAS in oncology or soluble guanylate cyclase in cardiovascular disease, rather than the group as a whole.
Not applicable for a broad enzyme class.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanine-recognizing enzymes.